HHS Invites Public Feedback on Categories for Federal Vaccine Recommendations and Collaborative Clinical Decision-Making
-
By
-
Assistant Secretary for Public Affairs (ASPA)
-
August 21, 2026
Clinical Report: HHS Invites Public Feedback on Vaccine Recommendations
Overview
The U.S. Department of Health and Human Services has issued a Request for Information to gather public input on federal vaccine recommendation categories. This initiative aims to evaluate the clarity and sufficiency of existing categories and explore potential revisions.
Background
The categorization of vaccine recommendations is crucial for guiding healthcare decisions and ensuring public trust in vaccination programs. The current framework includes routine, risk-based, and shared clinical decision-making categories, which are essential for tailoring vaccine recommendations to individual patient needs.
Data Highlights
No numerical data or trial data was provided in the source material.
Key Findings
- The RFI seeks feedback on the clarity and sufficiency of current vaccine recommendation categories.
- Considerations for feedback include evidence quality, personal autonomy, and informed consent.
- Responses will inform the Task Force on Safer Childhood Vaccines regarding potential improvements to the recommendation framework.
Clinical Implications
Healthcare providers should be aware of the ongoing evaluation of vaccine recommendation categories.
Conclusion
The HHS initiative invites public engagement in the development of vaccine recommendations.
Related Resources & Content
- U.S. Department of Health and Human Services, HHS Invites Public Feedback on Vaccine Recommendations, 2026 -- HHS Invites Public Feedback on Categories for Federal Vaccine Recommendations and Collaborative Clinical Decision-Making
- MDSpire News — HHS Announces Department-Wide Clinical Trial Initiative
- kff health news — Who Holds the Power on Vaccines Now?
- Stat News — New ACIP charter broadens criteria for members, calls for review of alternatives to vaccines
- United States Department of Health and Human Services — HHS Launches Unprecedented Department-Wide Effort to Restore American Leadership in Clinical Trials
- Delivering Gold Standard Childhood Vaccine Recommendations for Americans
- ACIP Shared Clinical Decision-Making Recommendations
- Preventive Services Coverage
- ACIP Charter | ACIP | CDC
- FAQs about Affordable Care Act and Coronavirus Aid, Relief, and Economic Security Act Implementation Part 59 | U.S. Department of Labor
- CENTER FOR MEDICARE
- Pneumococcal Vaccine Recommendations | Pneumococcal | CDC
- Interim Clinical Considerations for Use of COVID-19 Vaccines in the United States | Covid | CDC
- RSV Vaccine Guidance for Adults | RSV | CDC
- Vaccines for Adults | RSV | CDC
- Real-World Effectiveness of RSVpreF and RSVpreF3 Vaccines in Preventing Hospitalization and Emergency Department Visits Associated With Respiratory Syncytial Virus in Older Adults: A Meta-analysis - PubMed
- Real-world evidence on RSV vaccine uptake, effectiveness, and safety in older adults: a systematic review and meta-analysis - PMC
- Real-world evidence on RSV vaccine uptake, effectiveness, and safety in older adults: a systematic review and meta-analysis - PubMed
- RSV Prefusion F Vaccine for Prevention of Hospitalization in Older Adults | New England Journal of Medicine
- Evidence to Recommendations Frameworks | ACIP | CDC
Based on findings from:
HHS Seeks Public Input on Federal Vaccine Recommendation Categories and Shared Clinical Decision-Making
Assistant Secretary for Public Affairs (ASPA). United States Department Of Health And Human Services, 2026.
https://www.hhs.gov/press-room/hhs-seeks-public-input-federal-vaccine-recommendations.html
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
